Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (684)	5/18/2005 1:07:44 AM
From: Jibacoa	Read Replies (1) of 3722

Re: RGEN The stock has been performing better for the last week, but no news about any patents or results of their PII of RG1068, in schizophrenic patients. They reported an "Agreement" with ChiRhoClin,under which they will receive a payment of $750,000 and will be entitled to continue to market SecreFlo™ for the next several years under a royalty structure more favorable to RGEN than under the present Licensing Agreemen.RGEN is also not required to pay approximately $1.2M of disputed royalties and will record this amount as other income in the Q endeding on June 30. The stock started on a near term uptrend on May 10, but it still needs to close above its Apr.11 H of 2.04 The Relative Strenght Index has increased from 20 to 80 in the last week. The PSML & PS on RGEN at present: 1.87 1.82 1.78 1.81 & 1.70 (The L is still above the S & the M averages, but there seems to be good support at the 1.70 level.<g>) bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next